BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
27.73
-1.02 (-3.55%)
At close: Oct 16, 2025, 4:00 PM EDT
28.28
+0.55 (1.98%)
After-hours: Oct 16, 2025, 5:19 PM EDT
BioLife Solutions Revenue
BioLife Solutions had revenue of $25.42M in the quarter ending June 30, 2025, with 28.94% growth. This brings the company's revenue in the last twelve months to $93.47M, up 68.16% year-over-year. In the year 2024, BioLife Solutions had annual revenue of $82.25M with 8.44% growth.
Revenue (ttm)
$93.47M
Revenue Growth
+68.16%
P/S Ratio
13.93
Revenue / Employee
$587,849
Employees
159
Market Cap
1.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 82.25M | 6.40M | 8.44% |
Dec 31, 2023 | 75.86M | -384.00K | -0.50% |
Dec 31, 2022 | 76.24M | -42.92M | -36.02% |
Dec 31, 2021 | 119.16M | 71.07M | 147.79% |
Dec 31, 2020 | 48.09M | 20.72M | 75.69% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
BLFS News
- 9 days ago - BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary - PRNewsWire
- 15 days ago - BioLife: Back To Basics Is Getting Traction (Rating Upgrade) - Seeking Alpha
- 2 months ago - BioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioLife Solutions Reports Second Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - BioLife Solutions Makes Strategic Investment in Pluristyx - PRNewsWire
- 3 months ago - BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025 - PRNewsWire
- 5 months ago - BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025 - PRNewsWire
- 5 months ago - BioLife Solutions, Inc. (BLFS) Q1 2025 Earnings Call Transcript - Seeking Alpha